KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

Data as of 12:41pm ET
 -0.0059 / -1.35%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

KaloBios Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of monoclonal antibody therapeutics. It develops a portfolio of proprietary and patient-targeted monoclonal antibodies designed to treat severe life-threatening or debilitating diseases for which there is an unmet medical need, with a clinical focus on severe respiratory diseases and cancer. The company's antibody technology, Humaneered, treats serious medical conditions with a primary clinical focus on respiratory diseases and cancer. KaloBios Pharmaceuticals was founded on March 15, 2000 and is headquartered in South San Francisco, CA.

Contact Information

KaloBios Pharmaceuticals, Inc.
260 East Grand Avenue
South San Francisco California 94080
P:(650) 243-3100
Investor Relations:



Individual stakeholders31.85%
Other institutional27.46%
Mutual fund holders21.86%

Top Executives

Herbert C. CrossChief Executive & Financial Officer
Geoffrey Thomas YarrantonCSO, Executive VP-Research & Development
Néstor A. MolfinoChief Medical Officer
Harry LamSenior Vice President-Technical Operations
Anne Borgman HageyAssociate Chief Medical Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.